HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Mometasone Furoate Monohydrate

HCID 9893453
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
141646-00-6
Standard SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl.O
InChIKey
AQCCVUHZMIMSIB-HRVPQZBTSA-N
Molecular formula
C27H32Cl2O7
Average molar mass
539.4 g/mol
Monoisotopic mass
538.1525087

Overview

See other relationships...

Names & identifiers

Preferred name
Mometasone Furoate Monohydrate
IUPAC
[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;hydrate
English name
Mometasone furoate hydrate
Molecular formula
C32H34Cl2O9
Molecular weight
633.51296

Names & synonyms

141646-00-6Mometasone furoate hydrateMOMETASONE FUROATE MONOHYDRATEMTW0WEG809RYALTRIS COMPONENT MOMETASONE FUROATE MONOHYDRATETopcare Allergyup and up allergyLeader Allergy NasalRefChem:55662Rugby mometasone furoate nasalNasonex[(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate;hydrate
Show more names
SCH 32088 hydrateMometasone Furoate Monohdrate(9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate,hydrate
Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, hydrate (1:1), (11beta,16alpha)-MFCD08141820(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate hydrateMometasone furoate hydrate (JAN)MOMETASONE FUROATE HYDRATE [JAN]UNII-MTW0WEG809Nasonex (TN)SCHEMBL142487

Database identifiers

CAS
141646-00-6
PubChem CID
9893453
UNII
MTW0WEG809
EC Number
685-620-5

Properties

Computed structural properties

Topological polar surface area
94.8 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
7
Rotatable bonds
5
Heavy atoms
36
Formal charge
0
Complexity
1,020

Experimental & physicochemical properties

Animal DrugsFDA approved animal drugs -> Active ingredient

Physicochemical properties

storage temp.
2 · 2-8°C
solubility
100 mg/mL · DMSO: 100 mg/mL (157.85 mM);Ethanol: 3 mg/mL (4.74 mM)
Water Solubility
Water: Insoluble
InChIKey
QYXKWOXXTILOMD-DJIMNEDNNA-N
SMILES
C[C@]12C[C@H](OC(=O)C3=CC=CO3)C3([C@](CCC4[C@]3(C)C=CC(=O)C=4)([H])[C@]1([H])C[C@@H](C)[C@]2(OC(=O)C1OC=CC=1)C(=O)CCl)Cl.[H]O[H] |&1:1,3,13,17,25,28,30,r|
FDA UNII
0 WEG809 · MTW0WEG809
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H331 (66.7%): Toxic if inhaled [Danger Acute toxicity, inhalation]

P203, P260, P261, P271, P273, P280, P304+P340, P316, P318, P319, P321, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 18 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (66.7%)

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Pharmacology

FDA Pharmacological Classification · 2 items

MOMETASONE FUROATE MONOHYDRATE

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

MeSH Pharmacological Classification · 3 items

Substances that reduce or suppress INFLAMMATION.

Drugs used to treat or prevent skin disorders or for the routine care of skin.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes